| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/05/2000 | EP0968299A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 01/05/2000 | EP0968298A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 01/05/2000 | EP0968293A1 Staphylococcus 3-dehydroquinate synthase |
| 01/05/2000 | EP0968291A2 Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968288A1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a |
| 01/05/2000 | EP0968287A2 Secreted proteins and polynucleotides encoding them |
| 01/05/2000 | EP0968285A1 Morphogenic proteins |
| 01/05/2000 | EP0968284A2 An improved method for the production and purification of adenoviral vectors |
| 01/05/2000 | EP0968277A1 Filtration method for separating viruses |
| 01/05/2000 | EP0968276A1 NOVEL clpL |
| 01/05/2000 | EP0968225A1 NOVEL spsB |
| 01/05/2000 | EP0968224A1 Chimeric mutational vectors having non-natural nucleotides |
| 01/05/2000 | EP0967996A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 01/05/2000 | EP0967990A1 UDP-N-ACETYLMURAMOYL-L-AIANINE:D-GLUTAMATE LIGASE (murD) OF STAPHYLOCOCCUS AUREUS |
| 01/05/2000 | EP0967928A1 Method and apparatus for altering the osmotic pressure of cryopreserved white stem cells |
| 01/05/2000 | EP0967878A1 Targeted cytotoxic cells |
| 01/05/2000 | EP0776360A4 Dual fiber bioreactor |
| 01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
| 01/05/2000 | DE19829853A1 Verfahren zur interspezifischen Hybridisierung Method for interspecific hybridization |
| 01/05/2000 | DE19819476C1 Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins Polypeptide having immunogenic properties and altered biological function of a protein |
| 01/05/2000 | CN1240484A Methods for conferring insect resistance to a monocot using a peroxidase coding sequence |
| 01/05/2000 | CN1240483A Nematode-inducible regulatory DNA sequences |
| 01/05/2000 | CN1240481A Infections clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 01/05/2000 | CN1240479A Truncated soluble tumor necrosis factor type-I and type-II receptors |
| 01/05/2000 | CN1240476A Novel genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and their use |
| 01/04/2000 | US6011201 β-Ketoacyl ACP reductase genes from Brassica napus |
| 01/04/2000 | US6011198 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 01/04/2000 | US6011197 Method of cloning bovines using reprogrammed non-embryonic bovine cells |
| 01/04/2000 | US6011139 Polypeptides |
| 01/04/2000 | US6011137 Fusion proteins |
| 01/04/2000 | US6010905 Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
| 01/04/2000 | US6010903 Anti-human ceruloplasmin monoclonal antibody |
| 01/04/2000 | US6010897 Expression of signal-peptide-free staphylokinases |
| 01/04/2000 | US6010894 Using brain membrane receptor; forming vaccines |
| 01/04/2000 | US6010886 Receptor for oncostatin M |
| 01/04/2000 | US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides |
| 01/04/2000 | US6010879 Polynucleotides encoding human mitochondrial chaperone proteins |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010873 Modified complement system regulators |
| 01/04/2000 | US6010701 Cell proliferator and applications thereof |
| 01/04/2000 | US6010697 Cancer aftertreament |
| 01/04/2000 | US6010696 Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
| 01/04/2000 | US6010694 Fibrillin 1 gene comprising duplication mutation and compositions and kits using the same |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 01/04/2000 | CA1340869C T cell activation markers |
| 12/29/1999 | WO1999067644A1 Assay to indicate the presence of non-fertilisable ova |
| 12/29/1999 | WO1999067415A1 Novel molecules of the t110-related protein family and uses thereof |
| 12/29/1999 | WO1999067402A2 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana |
| 12/29/1999 | WO1999067399A1 HUMAN GLYCOPROTEASE-LIKE PROTEINS AND DNAs ENCODING THESE PROTEINS |
| 12/29/1999 | WO1999067393A2 Aav scleroprotein, production and use thereof |
| 12/29/1999 | WO1999067391A1 Origin of replication and methods of use |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067377A1 Human arf-related proteins |
| 12/29/1999 | WO1999067365A1 A method for in vitro maturation of human gametes |
| 12/29/1999 | WO1999067363A1 Ependymal neural stem cells and method for their isolation |
| 12/29/1999 | WO1999067362A1 Process for the in vitro replication of hcv |
| 12/29/1999 | WO1999067361A1 Allelic series of genomic modifications in cells |
| 12/29/1999 | WO1999067360A2 Media and methods for expansion of erythroid stem cells for the production of hemoglobin |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067289A1 A method for inducing production of growth factors |
| 12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 12/29/1999 | WO1999058681A3 Transgenic plant cells expressing a recombinant plant e2f peptide |
| 12/29/1999 | WO1999058563A3 Moraxella catharralis proteins |
| 12/29/1999 | WO1999057284A3 Attenuated influenza viruses |
| 12/29/1999 | WO1999057140A3 Growth-associated protease inhibitor heavy chain precursor |
| 12/29/1999 | WO1999051779A3 Glaucoma therapeutics and diagnostics |
| 12/29/1999 | WO1999049050A3 Limanthes oil genes |
| 12/29/1999 | WO1999047156A3 Compositions for modulating cell differentiation comprising a lipid and a morphogen |
| 12/29/1999 | WO1999043802A3 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 12/29/1999 | WO1999042564A3 Apoptotic cell-mediated antigen presentation to dendritic cells |
| 12/29/1999 | WO1999037755A3 The use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 12/29/1999 | EP0967284A1 Phosphodiesterases |
| 12/29/1999 | EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics |
| 12/29/1999 | EP0967278A2 Flowering regulating gene and its use |
| 12/29/1999 | EP0967277A2 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 12/29/1999 | EP0967273A1 Cell supporting matrix, cell culture device, and fluid treating device |
| 12/29/1999 | EP0967270A1 Epidermal cell growth activating material |
| 12/29/1999 | EP0967226A2 Methods for the production of fibrillar collagen |
| 12/29/1999 | EP0967225A1 ATP-sensitive potassium channel gene (Kir6.2/BIR)-deficient animals |
| 12/29/1999 | EP0966540A1 Mass production of paclitaxel by changing the temperature of the medium during the plant cell culture |
| 12/29/1999 | EP0966538A1 Replication-competent recombinant sabin type 1 strain of poliovirus |
| 12/29/1999 | EP0966537A2 AN $i(EX VIVO) ANIMAL OR CHALLENGE MODEL AS METHOD TO MEASURE PROTECTIVE IMMUNITY DIRECTED AGAINST PARASITES AND VACCINES SHOWN TO BE PROTECTIVE IN SAID METHOD |
| 12/29/1999 | EP0966534A1 Compositions and methods for elimination of unwanted cells |
| 12/29/1999 | EP0966533A1 Activity dependent neurotrophic factor iii (adnf iii) |
| 12/29/1999 | EP0966532A1 Biological material for treating a mammal by antibody gene transfer and pharmaceutical composition containing same |
| 12/29/1999 | EP0966530A2 Secreted proteins and polynucleotides encoding them |
| 12/29/1999 | EP0966523A1 Method for the production of selected lymphocytes |
| 12/29/1999 | EP0966522A1 Human liver cell line |
| 12/29/1999 | EP0966521A1 Cells having dna insertion mutations which produce altered amounts of a polypeptide |
| 12/29/1999 | EP0966484A1 Neurotactin and uses therefor |
| 12/29/1999 | EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 12/29/1999 | EP0966480A2 Cysteine-depleted peptides recognized by a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/29/1999 | EP0966292A1 Mononuclear phagocytes and their use to promote axonal regeneration |
| 12/29/1999 | EP0774005B1 Surface expression of enzyme in gene directed prodrug therapy |
| 12/29/1999 | EP0635062B1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA |
| 12/29/1999 | EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems |